Wird geladen...
TSC1 promotes iNKT cell anergy and inhibits iNKT cell-mediated anti-tumor immunity
Development of effective immune therapies for cancer patients requires better understanding of hurdles that prevent the generation of effective anti-tumor immune responses. Administration of α-galactosylceramide (α-GalCer) in animals enhances anti-tumor immunity via activation of the invariant natur...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3965184/ https://ncbi.nlm.nih.gov/pubmed/24532578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1302076 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|